Dr. Lilit Karapetyan, MD

  • Tampa, FL
  • Hematologist and oncologist
NPI1174973135PAC ID8729311980
Medicare services, 2024
164
Medicare patients, 2024
97
Part D claims, 2024
99
Publications
38
MIPS score, 2024
88
Practice address
12902 Magnolia Dr, Tampa, FL 33612
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Moffitt Cancer Hospital

Hospital · Tampa, Florida

See all 5 affiliations

Find Dr. Karapetyan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Lilit Karapetyan is a hematologist and oncologist in Tampa, Florida

Dr. Karapetyan practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Karapetyan's NPI, 1174973135, was assigned on June 20, 2016. Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019. Dr. Karapetyan holds Florida license ME156866.

NPI and contact details
Medicare PAC ID
8729311980
NPI enumeration date
June 20, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
41
Medical school graduation
2019

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Lilit Karapetyan practices at 2 locations in Tampa, Florida

Dr. Karapetyan's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Karapetyan also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

  • Moffitt Cancer HospitalPrimary
    12902 Magnolia Dr, Tampa, FL 33612
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
    10920 McKinley Dr, Tampa, FL 33612 · Hillsborough CountyPhone(813) 745-4673

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Lilit Karapetyan is affiliated with 4 sites of care and 1 medical group

Dr. Karapetyan's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Karapetyan to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

See all 5 affiliations for Dr. Karapetyan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Lilit Karapetyan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karapetyan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Moffitt Cancer HospitalAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Karapetyan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Lilit Karapetyan is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Karapetyan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Karapetyan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Karapetyan's licenses on file in 4 states: Florida, Ohio, Pennsylvania and Michigan.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME156866 · 2022 to 2026 · taxonomy 207RH0003X
  • Ohio licenseSince 2018
  • Pennsylvania license2019 to 2022
  • Internal medicine, MichiganLicense 4351043195 · 2016 to 2019 · taxonomy 207R00000X

Clinical focus

Dmand AI lists lymphoma among the conditions Dr. Karapetyan treats.

Hematologists and oncologists near Dr. Karapetyan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Lilit Karapetyan billed Medicare for 164 services in 2024

CMS data shows 164 Medicare services from Dr. Karapetyan across 3 procedure codes in 2024, all of them office visits, for 97 Medicare patients. Medicare paid $19,027 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024164
Medicare patients97
Paid by Medicare$19,027
Procedure codes3

Dr. Karapetyan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1512024: 1649%

Dr. Karapetyan compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Karapetyan
  • Florida median
Medicare services
164vs 69776% below
Medicare patients
97vs 21856% below
Part D claims
13vs 34196% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Karapetyan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Karapetyan

Need commercial claims for Dr. Karapetyan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Karapetyan and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Lilit Karapetyan treated 97 Medicare patients in 2024, average age 75

CMS counts 97 Medicare patients who saw Dr. Karapetyan in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karapetyan's median patient age at 70, with 38% women.

Medicare patients, 202497
Average age75
Average risk score2.35

Dr. Karapetyan's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Karapetyan's Medicare patients by sex, 2024

  • Women3637%
  • Men6163%

Chronic conditions among Dr. Karapetyan's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis45%
  4. Ischemic heart disease42%
  5. Chronic kidney disease33%
  6. Anxiety31%
  7. Cancer27%
  8. Diabetes26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Karapetyan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women38%
  • Men62%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Lilit Karapetyan wrote 99 Medicare Part D claims in 2024

In 2024, Dr. Karapetyan wrote 99 Medicare Part D claims for 39 patients. 82% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $165 in total drug cost. In 2018, CMS named 12 claims across 1 drug.

Part D claims, 202499
Drugs named by CMS1
Total drug cost$165
Part D patients39

Dr. Karapetyan's Part D claims by kind of drug, 2024

  • Generic81 claims82%
  • Brand-name18 claims18%

Dr. Karapetyan's most prescribed drugs by claims, 2019

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2018 to 2019

  • 2018
  • 2019
Claims for drugs CMS names
2018: 122019: 138%

Drugs named by CMS: 1 in 2019, 1 in 2018.

See all prescribing by Dr. Karapetyan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Lilit Karapetyan scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Karapetyan for performance year 2024, reported as part of a group. Dr. Karapetyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karapetyan as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Karapetyan's MIPS scores, performance year 2024

  • 88of 100Final score
  • 74of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Karapetyan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Lilit Karapetyan has 38 publications on record

Dmand AI links 38 papers to Dr. Karapetyan, published from 2016 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Melanoma, Skin Neoplasms and Immunotherapy. Dr. Karapetyan has published most often in J Immunother Cancer. Dr. Karapetyan's most frequent co-authors are Jason J. Luke, MD, Andrew David Knight, MD and Heather S. Laird-Fick, MD.

Papers38
Years published2016 to 2024

Dr. Karapetyan's papers by year, 2016 to 2024

Topics Dr. Karapetyan writes about most

  • Melanoma
  • Skin Neoplasms
  • Immunotherapy
  • Immune Checkpoint Inhibitors
  • Antineoplastic Agents
  • Carcinoma, Squamous Cell
  • Melanoma, Cutaneous Malignant
  • Neoplasm Metastasis

Dr. Karapetyan's most frequent co-authors

Recent publications by Dr. Karapetyan

See all 38 publications and co-authors

See who Dr. Karapetyan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karapetyan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Lilit Karapetyan received $257 in industry payments from 2018 to 2023

CMS Open Payments shows 3 general payments to Dr. Karapetyan from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 61% of the total. Sun Pharmaceutical Industries Inc. paid the most, $146.

General payments to Dr. Karapetyan by program year, 2018 to 2023

General payments to Dr. Karapetyan by kind, 2018 to 2023

$257in total
  • Food and beverage$15761%
  • Education$10039%

Companies that paid Dr. Karapetyan the most, 2018 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Karapetyan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Lilit Karapetyan graduated from College of Human Medicine - Grand Rapids

Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019.

  1. Medical schoolCollege of Human Medicine - Grand Rapids
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Lilit Karapetyan accepts plans from 5 insurance carriers

Dr. Karapetyan is in network with 5 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Humana. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Humana
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare

Plan types Dr. Karapetyan accepts, by number of carriers

  1. HMO3
  2. Medicare3
  3. PPO3
  4. POS2
  5. EPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Lilit Karapetyan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Lilit Karapetyan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Lilit Karapetyan's NPI number?

Dr. Lilit Karapetyan's NPI number is 1174973135. It was assigned on June 20, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Lilit Karapetyan?

Dr. Lilit Karapetyan is a hematologist and oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Lilit Karapetyan practice?

Dr. Karapetyan practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Karapetyan also practices at 10920 McKinley Dr, Tampa, FL 33612. Dr. Karapetyan's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dmand AI also links Dr. Karapetyan to 1 breast imaging center, 1 group practice or clinic and 1 hospital outpatient department.

What is Dr. Lilit Karapetyan's medical license number?

Dr. Karapetyan holds Florida license ME156866, one of the licenses on file in 4 states.

Which states has Dr. Lilit Karapetyan been licensed in?

Dmand AI has state licenses on file for Dr. Karapetyan in Florida (2022 to 2026), Ohio (since 2018), Pennsylvania (2019 to 2022) and Michigan (2016 to 2019).

Which hospitals is Dr. Lilit Karapetyan affiliated with?

Dr. Karapetyan practices at Moffitt Cancer Hospital in Tampa, Florida.

What medical group is Dr. Lilit Karapetyan part of?

Dr. Karapetyan is linked to Moffitt Cancer Center.

Does Dr. Lilit Karapetyan accept Medicare?

Yes. CMS data shows Dr. Karapetyan billed Medicare for 164 services in 2024, and Dr. Karapetyan accepts Medicare assignment.

Does Dr. Lilit Karapetyan offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Karapetyan as offering telehealth services.

What is Dr. Lilit Karapetyan's MIPS score?

Dr. Karapetyan's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Lilit Karapetyan see?

CMS counts 97 Medicare patients who saw Dr. Karapetyan in 2024, with an average age of 75.

Is Dr. Lilit Karapetyan board certified?

Yes. Dr. Karapetyan is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Lilit Karapetyan bill to Medicare?

In 2024, Dr. Karapetyan's most billed Medicare services were office visit, established patient (99215), office visit, new patient (99205) and office visit, established patient (99214).

Where did Dr. Lilit Karapetyan go to medical school?

Dr. Karapetyan graduated from College of Human Medicine - Grand Rapids in 2019.

What drugs does Dr. Lilit Karapetyan prescribe most?

In 2019 Medicare Part D data, Dr. Karapetyan's most prescribed drugs by claims were Atorvastatin Calcium.

Has Dr. Lilit Karapetyan received payments from drug or device companies?

CMS Open Payments shows $257 in general payments to Dr. Karapetyan from 3 companies from 2018 to 2023. The largest total came from Sun Pharmaceutical Industries Inc.

How long has Dr. Lilit Karapetyan been practicing?

Dr. Karapetyan graduated from medical school in 2019, 7 years ago.

Does Dr. Lilit Karapetyan do research?

Dmand AI links 38 publications to Dr. Karapetyan, published from 2016 to 2024.

Who does Dr. Lilit Karapetyan publish with?

Dr. Karapetyan's most frequent co-authors are Jason J. Luke, MD (6 shared papers), Andrew David Knight, MD (5 shared papers) and Heather S. Laird-Fick, MD (4 shared papers).

What insurance does Dr. Lilit Karapetyan accept?

Dr. Karapetyan is in network with 5 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Humana. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)